clotrimazole has been researched along with Vaginal Diseases in 12 studies
Vaginal Diseases: Pathological processes of the VAGINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind study was conducted comparing a 3-day (200 mg once a day for 3 consecutive days) treatment with a 6-day (100 mg once a day for 6 consecutive days) treatment of clotrimazole in patients with vaginal mycoses." | 5.05 | Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets. ( Cho, N; Mizuno, S, 1983) |
| "The purpose of this study was to develop a suitable mucoadhesive in situ gel formulation of clotrimazole (CLO) for the treatment of vaginal candidiasis." | 3.85 | Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation. ( Baloğlu, E; Eraç, B; Karavana, SY; Limoncu, MH; Rençber, S; Şenyiğit, ZA, 2017) |
| " There have been no published comparisons with nystatin vaginal cream or foaming vaginal tablets - nystatin dosage forms preferred by some clinicians." | 2.35 | Clotrimazole: a review of its antifungal activity and therapeutic efficacy. ( Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM, 1975) |
| "The introduction of clotrimazole into the therapy of vaginal Candida and Torulopsis infections has significantly shortened the previously customary duration of treatment and reduced the frequency of dosage of the active ingredient." | 1.26 | On the action kinetics of clotrimazole. ( Plempel, M, 1982) |
| " In order to investigate the fate of clotrimazole reaching systemic circulation, pharmacokinetic studies following oral and intravenous administration were carried out." | 1.26 | Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. ( Krause, U; Patzschke, K; Ritter, W; Stettendorf, S, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rençber, S | 1 |
| Karavana, SY | 1 |
| Şenyiğit, ZA | 1 |
| Eraç, B | 1 |
| Limoncu, MH | 1 |
| Baloğlu, E | 1 |
| Della Casa, V | 1 |
| Noll, H | 1 |
| Gonser, S | 1 |
| Grob, P | 1 |
| Graf, F | 1 |
| Pohlig, G | 1 |
| Mizuno, S | 1 |
| Cho, N | 1 |
| Forcucci, M | 1 |
| Bondi, G | 1 |
| Zulli, P | 1 |
| Carosi, M | 1 |
| Faravelli, M | 1 |
| Plempel, M | 1 |
| Ritter, W | 1 |
| Patzschke, K | 1 |
| Krause, U | 2 |
| Stettendorf, S | 1 |
| Szalóczy, P | 1 |
| Kusnyerik, G | 1 |
| Pook, D | 1 |
| Sawyer, PR | 1 |
| Brogden, RN | 1 |
| Pinder, RM | 1 |
| Speight, TM | 1 |
| Rzepka, I | 1 |
| Facchini, V | 1 |
1 review available for clotrimazole and Vaginal Diseases
| Article | Year |
|---|---|
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
Topics: Amoeba; Animals; Candidiasis; Clotrimazole; Dogs; Drug Resistance, Microbial; Female; Fungi; Humans; | 1975 |
2 trials available for clotrimazole and Vaginal Diseases
| Article | Year |
|---|---|
Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets.
Topics: Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Male; | 1983 |
[Vaginal infections of mixed etiology. Clinical importance and study of the efficacy and tolerability of 2 different treatments (25,000 I.U. mepartricin vaginal tablets and 100 mg. clotrimazole vaginal tablets)].
Topics: Adult; Bacterial Infections; Clotrimazole; Drug Tolerance; Female; Humans; Imidazoles; Mepartricin; | 1984 |
9 other studies available for clotrimazole and Vaginal Diseases
| Article | Year |
|---|---|
Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Topics: Adhesiveness; Administration, Intravaginal; Animals; Anti-Infective Agents, Local; Antifungal Agents | 2017 |
Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections.
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Bacteria; Bacteria, Aerobic; Bacteria, Ana | 2002 |
On the action kinetics of clotrimazole.
Topics: Candida albicans; Clotrimazole; Culture Media; Female; Humans; Imidazoles; Kinetics; Miconazole; Pat | 1982 |
Pharmacokinetic fundamentals of vaginal treatment with clotrimazole.
Topics: Carbon Radioisotopes; Clotrimazole; Female; Humans; Imidazoles; Kinetics; Mycoses; Time Factors; Vag | 1982 |
Results of single-dose treatment of vaginal mycoses with 500 mg Canesten vaginal tablets.
Topics: Adolescent; Adult; Aged; Clotrimazole; Female; Humans; Imidazoles; Middle Aged; Mycoses; Tablets; Ti | 1982 |
Canesten treatment of vaginal mycoses during pregnancy.
Topics: Clotrimazole; Female; Humans; Imidazoles; Infant, Newborn; Mycoses; Pregnancy; Pregnancy Complicatio | 1980 |
[The efficacy of clotrimazole].
Topics: Administration, Topical; Adolescent; Adult; Candidiasis; Clotrimazole; Female; Humans; Imidazoles; M | 1980 |
[The effectiveness of Clotrimazol in the treatment of vaginal mycoses in girls].
Topics: Adolescent; Child; Clotrimazole; Female; Humans; Imidazoles; Mycoses; Vaginal Diseases | 1976 |
[Value of clotrimazole (BAY B 5097 or Canesten) as an antimycotic, antiprotozoal and antibacterial agent in vulvo-vaginal inflammations].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Candidiasis, Vulvovaginal; Clotrimazole; Female; Huma | 1974 |